DRUG PRODUCT CHA
RACTERIZATION STUDIES
................................................
32
A.
Priming and Repriming in Various Orientations
................................................................
33
B.
Effect of Resting Time
.........................................................................................................
33
C.
Temperature Cycling
..........................................................................................................
33
D.
In Vitro Dose Proportionality
.............................................................................................
34
E.
Cleaning Instructions
..........................................................................................................
34
F.
Device Robustness
34
G.
Effect of Dosing Orientation
...............................................................................................
34
H.
Effect of Varying Flow Rates
..............................................................................................
35
I.
Profiling of Sprays Near Container Exhaustion (Tail Off Characteristics)
35
J.
Effect of Storage on the Particle Size Distribution
..............................................................
35
K.
Plume Geometry
.................................................................................................................
36
L.
Pr
eservative Effectiveness and Sterility Maintenance
.........................................................
36
M.
Characterization of Nebulizer Specified in the Labeling
.....................................................
36
N.
Photostability
36
O.
Stability of Primary (Unprotecte
d) Package
........................................................................
37
V.
LABELING CONSIDER
ATIONS
37
A.
Nasal and Inhalation Spray Drug Products
37
B.
Inhalation Solutions and Suspensions
.................................................................................
40
...................................................................................................................
...................................................................
........................................................................................................................
...............................................................................................................
..........................
...................................................................................................................